Day: May 15, 2023

ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights

Written by Customer Service on May 15, 2023. Posted in Public Companies.

Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in Alzheimer’s disease Presented preclinical data supporting target identification and candidate differentiation across pipeline of antibody therapeutics at international neurology conferencesTORONTO, Ontario and CAMBRIDGE, Massachusetts , May 15, 2023 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced its first quarter 2023 financial results and recent highlights. “In the first quarter, we completed the required steps that...

embecta to Participate in Investor Conferences

Written by Customer Service on May 15, 2023. Posted in Public Companies.

PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following investor conferences: 2023 RBC Capital Markets Global Healthcare ConferenceManagement will host a fireside session on Tuesday, May 16, 2023, at 3:05 p.m. Eastern Time (ET) at the InterContinental Barclay, New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company’s investor relations website at investors.embecta.com.2023 Jefferies Global Healthcare ConferenceManagement will host a fireside session on Thursday, Jun 8, 2023, at 3:30 p.m. Eastern Time (ET) at the Marriott Marquis, New York. Audio webcasts of the presentations will be accessible...

Skyharbour Resources Engages Marketing Firm

Written by Customer Service on May 15, 2023. Posted in Public Companies.

Vancouver, BC, May 15, 2023 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) announces that the Company has entered into a consulting agreement with Marco Messina (“Messina”), a German based communications and media services provider, pursuant to which Messina will provide the Company with investor relations services. The consulting agreement has a term of nine (9) months, unless terminated earlier in accordance with its terms. The investor relations services provided by Messina will be in consulting with the Company’s management in building investor awareness of the Company through Messina’s network in Europe. The Company has agreed to pay Messina a total initial cost of EUR $85,000 upon the commencement of services. Messina is at arm’s length...

Enservco Corporation Reschedules 2023 1st Quarter Earnings Call to Tuesday, May 16, 2023, at 10:00 a.m. Eastern Time

Written by Customer Service on May 15, 2023. Posted in Public Companies.

LONGMONT, Colo., May 15, 2023 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional oil and gas industries, today announced it has rescheduled its 2023 first quarter earnings call to 10:00 a.m. ET on Tuesday May 16, 2023. The conference call will be accessible by dialing 888-506-0062 (973-528-0011 for international callers). A telephonic replay will be available through May 29, 2023, by calling 877-481-4010 (919-882-2331 for international callers) and entering the Replay ID # 48443. To listen to the webcast, participants should access the Enservco website, located at www.enservco.com, and link to the “Investors” page at least 10 minutes early to register. Participants can also connect directly at https://www.webcaster4.com/Webcast/Page/2228/48443 A...

First Watch Restaurant Group, Inc. Announces Secondary Offering of Common Stock

Written by Customer Service on May 15, 2023. Posted in Public Companies.

BRADENTON, Fla., May 15, 2023 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (“FWRG” or the “Company”) (NASDAQ: FWRG), a leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the launch of an underwritten secondary offering (the “Offering”) by certain funds managed by Advent International Corporation (the “Selling Stockholders”) of 3,500,000 shares of the Company’s common stock (“Common Stock”). The underwriter has a 30-day option to purchase up to an additional 525,000 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The Selling Stockholders will receive all of the proceeds from the Offering. The Company is not selling any shares of Common Stock in the Offering and will not receive any proceeds from the Offering. Jefferies LLC is acting as the...

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

Written by Customer Service on May 15, 2023. Posted in Earnings Releases And Operating Results.

Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data Expected in Mid-2023WARREN, N.J., May 15, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the first quarter ended March 31, 2023. “We are pleased with the progress we have made to date in 2023, highlighted by the completion of the blinded treatment phase of our ongoing pivotal Phase 3 REBUILD trial,” said Peter Fernandes, Bellerophon’s Chief Executive Officer. “We expect to report top-line results from the study in the middle of this year, a critical milestone for the Company. Importantly, following...

Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on May 15, 2023. Posted in Earnings Releases And Operating Results.

Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ET SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announced financial results for the first quarter ended March 31, 2023, and provided an update on recent corporate developments. Q1 2023 Corporate Highlights Nasdaq Continued ListingOn February 23, 2023, Adamis announced that Nasdaq had granted its request to extend the period for the Company to regain compliance with the $1 minimum bid share price requirement, subject to the Company evidencing compliance with all applicable criteria for continued listing,...

Onfolio Holdings Inc. Announces First Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on May 15, 2023. Posted in Earnings Releases And Operating Results.

WILMINGTON, Del., May 15, 2023 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (“Onfolio” or the “Company”), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of verticals, announces financial results for the first quarter of 2023. Recent Corporate HighlightsCompleted the acquisition of Contentellect, a provider of software that allows small and midsize businesses to scale their content with blog writing and link building, in February 2023 Appointed:Ravi Jayagopal as CEO of WPFolio, a WordPress plugin development company Tanya Vaughn as CEO of Proofread Anywhere, an online provider of resources for those looking to become professional proofreadersFirst Quarter 2023 Financial HighlightsFirst quarter 2023 revenue grew 250% year-over-year to $1.35...

PainReform Provides Business Update for the First Quarter of 2023

Written by Customer Service on May 15, 2023. Posted in Earnings Releases And Operating Results.

Reports Progress on Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery TEL AVIV, Israel, May 15, 2023 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended March 31, 2023. Ilan Hadar, Chief Executive Officer of PainReform, stated, “We have made significant progress advancing the Phase 3 clinical trial to evaluate PRF-110, our lead drug candidate, for post-surgical pain relief following bunionectomy surgery. Importantly, we announced the completion of treatment for the first part of Phase 3 clinical trial of PRF-110, in which 15 patients undergoing bunionectomy surgery were enrolled at...

Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on May 15, 2023. Posted in Earnings Releases And Operating Results.

Significant YTD Progress in Neurology and Oncology Programs New financing of $5MM closed without warrants, derivatives or other financial considerations ROCHESTER, N.Y., May 15, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease (NDD) and cancer through the inhibition of SEMA4D today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update on key programs and financing in the first five months of the year. “Vaccinex continues to make important progress in our clinical programs to develop pepinemab, our proprietary immunotherapy product candidate, to improve patient outcomes in neurodegenerative disease and cancer,” said Maurice Zauderer, Ph.D., President and Chief Executive...

Day: May 15, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals